| Patient | Fannie Lou Hamer |
|---|---|
| Date of birth | 1976-10-06 |
| Identifiers | MRN HR-ML031-SYN; SSN (made up) 000-31-2479 |
| Document date | 2026-07-13 |
| Author | Lorraine Batiste-Hill, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four-month review: A1c, urine albumin, kidney function, mood, social needs, and the metformin dose. [S]
Mrs. Hamer returns two months after her last review, brought by the health center's van as booked. Her home readings averaged 131/82 at the four-week phone check and 127/79 since, so no dose change was needed. She has had no low blood sugar, dizziness, cough or genital itching. She has finished the diabetes classes. The energy assistance was approved, and with SNAP and the produce program the food lasts through the month. She walks most days, though her legs ache. Her mood is steady. [S]
| Element | Detail |
|---|---|
| Home blood pressure | Average 127/79 |
| Diabetes classes | Completed |
| Benefits | SNAP and energy assistance in place |
| Mood | PHQ-9 3 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No dizziness; weight down 2 kg |
| Cardiovascular | Negative | No ankle swelling |
| Genitourinary | Negative | No burning or genital itching |
| Musculoskeletal | Positive | Leg aching after walking |
| Psychiatric | Negative | Mood steady |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin extended-release 500 mg oral tablet, one tablet with the evening meal for one week, then two tablets with the evening meal | Two tablets with the evening meal (after one week of one tablet) | Oral route | 2026-03-09 to 2026-07-13 | completed | S |
| Metformin extended-release 500 mg oral tablet, three tablets with the evening meal | Three tablets with the evening meal | Oral route | 2026-07-13 | active | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-09 | active | S |
| Amlodipine 5 mg and benazepril 20 mg combined oral capsule, one capsule daily | One capsule daily | Oral route | 2026-03-23 | active | S |
| Dapagliflozin 10 mg oral tablet, one tablet daily; stop on days of vomiting, diarrhea or not eating, and before surgery | One tablet daily, with sick-day rules | Oral route | 2026-03-23 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-13 | Body height | 163 | cm | S |
| 2026-07-13 | Body weight | 90.9 | kg | S |
| 2026-07-13 | Body mass index (BMI) [Ratio] | 34.2 | kg/m2 | S |
| 2026-07-13 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-07-13 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-07-13 | Heart rate | 76 | /min | S |
| 2026-07-13 | Respiratory rate | 16 | /min | S |
| 2026-07-13 | Body temperature | 36.9 | Cel | S |
| 2026-07-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-13 | Hemoglobin A1c/Hemoglobin.total in Blood | 7.3 | % | Below 5.7% is normal; 6.5% or higher is diabetes; goal below 7% for her | High | S |
| 2026-07-13 | Albumin/Creatinine [Mass Ratio] in Urine | 52 | mg/g | Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2) | High | S |
| 2026-07-13 | Potassium [Moles/volume] in Serum or Plasma | 4.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-07-13 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-07-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 67 | mL/min/{1.73_m2} | 90 or higher is normal; 60 to 89 is mildly decreased (G2) | Low | S |
| 2026-07-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 2026-07-13 | Accountable health communities (AHC) health-related social needs screening (HRSN) tool | 1 | {score} | S |
Vital signs recorded on 2026-07-13; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Consent and chaperone | Blood draw, urine sample and examination explained and agreed; female nurse present |
| General | Well; blood pressure 128/78, pulse 76; weight 90.9 kg |
| Cardiovascular | Regular rhythm; no ankle swelling |
| Feet | Inspected with her agreement: callus smaller after trimming; no ulcers |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Type 2 diabetes with hyperglycemia, newly diagnosed: A1c 8.6% and random glucose 238 mg/dL with thirst and frequent urination; synthetic modern episode linked to the diabetes documented in her later life | active | confirmed | E11.65 | S — Synthetic modern diagnosis; diabetes is documented only at the end of her life. |
| Elevated blood pressure at intake (164/98 mmHg), without a diagnosis of hypertension; home readings for one week to confirm | resolved | confirmed | R03.0 | S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks. |
| Albumin in the urine (urine albumin-to-creatinine ratio 88 mg/g) and eGFR 73, in a woman whose kidneys were injured in a beating years ago; to be repeated and investigated | resolved | confirmed | R80.9 | S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks; the old kidney injury is documented. |
| Hypertension, stage 2, confirmed by home readings (average 152/94 mmHg), with chronic kidney disease; synthetic modern episode linked to the hypertension reported in her later life | active | confirmed | I12.9 | S — Synthetic modern diagnosis; hypertension is reported only at the end of her life. |
| Chronic kidney disease G2 A2 (eGFR 73, albumin-to-creatinine ratio 88 to 96 mg/g), with a small, scarred right kidney on ultrasound consistent with old injury; diabetes and high blood pressure likely contribute | active | confirmed | N18.2 | S — Synthetic kidney findings anchored to the documented permanent kidney damage. |
| Type 2 diabetes with diabetic chronic kidney disease (coded with the kidney disease by convention) | active | confirmed | E11.22 | S — Synthetic modern coding. |
| Food insecurity: food runs out before the end of most months | active | confirmed | Z59.41 | S — Synthetic social need found on the screen. |
| Transportation insecurity: no car; the health center is a long drive away and rides are hard to arrange | active | confirmed | Z59.82 | S — Synthetic social need anchored to her rural Delta home. |
| Hyperlipidemia: LDL 146 mg/dL | active | confirmed | E78.5 | S — Synthetic laboratory finding. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Consent and chaperone for every examination, test and procedure | Every visit | Completed today | Each step explained and agreed |
| Examination | Clinic blood pressure (seated, two readings, large cuff) | Every visit | Completed today | 128/78 |
| Self-management | Home blood pressure readings | Seven days to confirm the diagnosis; then twice a week, and daily for a week after any change | Completed today | Average 127/79 |
| Examination | Weight and BMI | Every visit | Completed today | 90.9 kg |
| Laboratory | Hemoglobin A1c | Every 3 months until at goal, then every 6 months | Completed today | 7.3%, from 8.6% |
| Laboratory | Urine albumin-to-creatinine ratio | Repeat to confirm; 3 to 6 months after a treatment change; then every 6 months while moderately increased | Completed today | 52 mg/g, from 96 |
| Laboratory | Potassium, creatinine and eGFR | One to two weeks after starting an ACE inhibitor, then every 6 months (more often with changes) | Completed today | Potassium 4.6 mmol/L; creatinine 1.02 mg/dL, eGFR 67 |
| Examination | Foot inspection, and comprehensive foot examination | Inspection every visit; comprehensive examination yearly | Completed today | Inspection: callus smaller; no ulcers |
| Medication safety | Medicine safety: low blood sugar, sick-day rules, genital infections, cough, swelling, adherence and cost | Every visit | Completed today | No low blood sugar, dizziness, cough or genital itching; metformin increased |
| Self-management | Diabetes self-management education and support | At diagnosis, then yearly and when needs change | Completed today | Classes completed |
| Survey | Depression screen (PHQ-9) | At intake, then every 6 to 12 months | Completed today | PHQ-9 3, asked privately |
| Survey | Social needs screen (AHC-HRSN) and resources | At intake, then every few months while needs are open | Completed today | One core need positive (transportation on some days); food and utility needs met |
Goal progress:
Guideline basis: Introduction and Methodology: Standards of Care in Diabetes-2026 (2026); 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026 (2026); 1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2026 (2026); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); CMID: Clinical Monitoring Intelligence Database, hypertension, diabetes type 2, hyperlipidemia, chronic kidney disease and depression monographs (2026); Trauma-Informed Care in Behavioral Health Services (Treatment Improvement Protocol 57) (2014); Code of Medical Ethics Opinion 2.1.1: Informed Consent (2026); The Accountable Health Communities Health-Related Social Needs Screening Tool (2017); Depression and Suicide Risk in Adults: Screening (2023)
Follow-up: Preventive visit in two months. Seven-month review in three months with the A1c, urine albumin, kidney function, the social needs screen and the autumn vaccines; rides booked. Next scheduled visit 2026-09-14: periodic adult preventive visit. [S]